cabozantinib,atezolizumab
exelixis,roche
['atezolizumab', 'cabozantinib', ' uc,(-ucsd),(-ucsf),']
cabozantinib in combination with atezolizumab demonstrated encouraging clinical activity in metastatic uc as first-line systemic therapy by #asco22 
Medical oncologist. Clinical researcher focused in GU tumors. Director Institute of Oncology. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain